Ads
-
Related paper
- The use of epoetin alfa biosimilar in the anemia management in hemodialysis patients
- INFLUENCE OF EPOETIN ALFA ON LEVEL OF PROINFLAMMATORY AND ANTIINFLAMMATORY CYTOKINE OF PATIENTS IN MAINTENCE HEMODIALYSIS
- Management of Anemia among Chronic Hemodialysis Patients: Monocentric Study of Morocco
- CORRECTING OF ANEMIA USING IRON SUCROSE IN PATIENTS WITH CHRONIC KIDNEYDISEASE STAGE VD ON HEMODIALYSIS
- OXIDATIVE STRESS IN THE PATIENTS WITH CKD V STAGE AND ANEMIA WHO RECEIVE REPLACEMENT HEMODIALYSIS THARAPY
- Anemia and the use of antihypertensive medications in hemodialysis patients: multicenter retrospective observational study
- The effects of L-carnitine supplement on anemia in hemodialysis patients: A randomized clinical trial study
- EFFICACY AND SAFETY OF IRON (III)–HYDROXIDE SUCROSE COMPLEX IN CORRECTION OF ANEMIA STAGE 5D CHRONIC KIDNEYDISEASE HEMODIALYSIS PATIENTS NOT TREATED BY ERYTHROPOIESIS–STIMULATING AGENTS (PROSPECTIVEANALYSIS)
- Health Teachings Rendered to Hemodialysis Patients as Perceived by Hemodialysis Patients and Staff Nurses
- PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION